2018
DOI: 10.1016/j.taap.2018.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles

Abstract: The complex genetic diversity of chronic lymphocytic leukemia (CLL) makes it difficult to determine the effective and durable therapy beneficial to patients. During the several past years' significant insights in the biology of the disease and its treatment have been made, allowing for the identification of promising novel therapeutic agents. The investigation of signaling pathways to understand the biological character of CLL together with the development of molecular profiling is key in personalized approach… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 57 publications
0
0
0
Order By: Relevance
“…Therefore, these cMS-NMs may not lead to the activation of apoptotic pathways through the BAK pathway. It should also be noted that NFKB1A, which is a subunit of the NF-kappa B transcription factor, plays a crucial role in regulating immune and inflammatory responses during inflammation [34,56,57]. When cells are exposed to foreign or toxic materials like cMS-NMs, NFKB1A can be modulated significantly.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, these cMS-NMs may not lead to the activation of apoptotic pathways through the BAK pathway. It should also be noted that NFKB1A, which is a subunit of the NF-kappa B transcription factor, plays a crucial role in regulating immune and inflammatory responses during inflammation [34,56,57]. When cells are exposed to foreign or toxic materials like cMS-NMs, NFKB1A can be modulated significantly.…”
Section: Resultsmentioning
confidence: 99%